Novartis Ag (NVS) Current Assets (2009 - 2025)

Novartis Ag (NVS) has 12 years of Current Assets data on file, last reported at $30.5 billion in Q4 2025.

• Quarterly Current Assets rose 2.55% year-over-year to $30.5 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.5 billion (up 2.55% YoY) and the FY2025 annual result came in at $30.5 billion, up 2.55% from the prior year.
• Current Assets advanced to $30.5 billion in Q4 2025 per NVS's latest filing, from $25.9 billion in the prior quarter.
• The five-year high for Current Assets was $45.7 billion in Q4 2021, with the low at $25.7 billion in Q2 2024.
• Average Current Assets over 5 years is $32.8 billion, with a median of $30.9 billion recorded in 2021.
• Year-over-year, Current Assets soared 54.07% in 2021 and slipped 23.29% in 2024.
• Novartis Ag's Current Assets stood at $45.7 billion in 2021, then decreased by 19.27% to $36.9 billion in 2022, then decreased by 17.42% to $30.5 billion in 2023, then slipped by 2.55% to $29.7 billion in 2024, then grew by 2.55% to $30.5 billion in 2025.
• Business Quant data shows NVS's Current Assets at $30.5 billion in Q4 2025, $25.9 billion in Q2 2025, and $29.7 billion in Q4 2024.